Longitudinal Single-Cell RNA Sequencing Reveals Evolution of Micro- and Macro-States in Chronic Myeloid Leukemia
Year: 2026
Type: article
Abstract: Single-cell RNA-sequencing (scRNA-seq) has revolutionized our understanding of cancer. However, identifying meaningful disease states from single-cell data remains challenging due to the complex continuum of transcriptional alterations, which may obscure clear phenotype boundaries and complicate biological interpretation and clinical relevance. Here, we systematically explored the chronic myeloid leukemia (CML) specific information content encoded in scRNA-seq versus bulk transcriptomics to resolve this paradox and clarify how discrete disease-defining states emerge from inherently noisy single-cell data. While CML single-cell transcriptomes existed along continuous transcriptional micro-states, clinically relevant leukemia phenotypes clearly manifested only at the pseudobulk (macro-state) level. State-transition theory was leveraged to reveal how disease phenotype state-transitions are governed by cell type specific contributions. Together, these results establish a theoretical framework explaining why discrete disease phenotypes remain hidden at the single-cell scale but emerge clearly at the aggregated macro-state level, enabling previously inaccessible biological insights into leukemia evolution. By resolving how single-cell variation aggregates into macroscopic disease states, this framework provides insights into CML progression and offers a broadly applicable strategy for exploring disease dynamics across cancers and other complex conditions.
Source: Cancer Research
Authors: David E. Frankhouser, Dandan Zhao, Yu-Hsuan Fu, Anupam Dey, Ziang Chen, Jihyun Irizarry, Jennifer Rangel Ambriz, Tiffany Kanesa Ybarra, Sergio Branciamore, Denis O’Meally, Ryan S. Sathianathen, Jeffery M. Trent, Stephen Forman, Adam L. MacLean, Ya-Huei Kuo, Kathleen M. Sakamoto, Bin Zhang, Russell C. Rockne, Guido Marcucci
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Funders: U.S. Department of Defense, Pediatric Cancer Research Foundation, American Society of Hematology, Alex's Lemonade Stand Foundation for Childhood Cancer, Leukemia and Lymphoma Society, National Institutes of Health, High Performance Research Computing, Texas A and M University, National Cancer Institute, National Institute of General Medical Sciences, Stanford Maternal and Child Health Research Institute, Altman Foundation
Awards: G1094766575, Targeting Immune Escape in CML/MPN Transformation, G1671829136, State-transition and leukemia potential dynamics to inform disease evolution and adaptive therapy, G772794905, TARGETING RSK FOR TREATMENT OF PEDIATRIC ACUTE MYELOID LEUKEMIA, G9000092632, G9000376258, G9000377012, Cancer Metabolism Training Program
OpenAlex ID: W4410467913
